Stocks

Annexon ANNX

Health care sectorNasdaq

What to see in Annexon now

Who bought more than 5%?6.0%

State Street holds 6%

Filed 08/07
Is Wall Street adding or cutting?−1

216 13F filers hold it · −1 against the quarter before · shares held +14.4%

Holdings of 06/30
Are insiders selling?+$99.8K

1 insiders, a net purchase of $99.8K in 90 days

Filed 09/25

Company

Exchange
Nasdaq
Industry
Pharmaceutical Preparations
Headquarters
Brisbane, California
Fiscal year end
12/31
Next earnings
11/14, estimated
  • 1 insiders, a net purchase of $99.8K in 90 daysFiled 09/25

Insider trades

Trade type
Douglas LovePRESIDENT AND CEO
Open-market buy09/2409/2526,065 sh$3.83$99,828.95+7.2%
Open-market buy05/2805/29613,497 sh$5.41$3,319,018.77+6.3%
Open-market buy10b5-1 plan05/1105/138,000 sh$5.78$46,240+11.4%
Open-market buy10b5-1 plan04/1004/148,000 sh$6.20$49,600+12.8%
Open-market buy10b5-1 plan03/1003/128,000 sh$5.67$45,360+14.7%
All insider trades in Annexon

Planned sales

Thomas G. WiggansFormer Director
AnnexonANNX
2,000 sh$10,59608/13Filed 08/13
Thomas G. WiggansFormer Director
AnnexonANNX
2,000 sh$12,630.0107/15Filed 07/15
Thomas G. WiggansFormer Director
AnnexonANNX
1,000 sh$5,60507/14Filed 07/14
AnnexonANNX
5,566 sh$30,181.0803/02Filed 03/02
AnnexonANNX
5,894 sh$31,979.6703/02Filed 03/02
AnnexonANNX
4,339 sh$23,529.9603/02Filed 03/02
AnnexonANNX
5,820 sh$31,579.3203/02Filed 03/02
AnnexonANNX
5,565 sh$30,178.4403/02Filed 03/02
AnnexonANNX
7,851 sh$40,119.402/18Filed 02/18
AnnexonANNX
5,290 sh$26,989.5802/18Filed 02/18
All planned sales of Annexon

26-week trading

No member of Congress reported a trade in Annexon ANNX in the past 90 days. Insiders filed 1 purchase and 0 sales on the open market over the same period, a net purchase of $99.8K.

Common questions

Did Annexon ANNX insiders buy or sell in the past 90 days?
In the past 90 days insiders filed 1 purchase and 0 sales on the open market. Purchases came to $99.8K.